Figure 2. Overall and disease-free survival in Z0011 eligible patients. (ALND = 1) represents node negative and (ALND = 2) node positive in completion ALND. In a median follow up of 40 (IQR 29, 54) months. (a): Four deaths in each ALND group (1&2). (b): Five recurrences in ALND (node negative) and three in ALND (node positive).
